Alex Arfaei Joins Pappas Capital As Partner

News | 09. 11. 2019

Sorriso Pharmaceuticals

RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2019 -- Pappas Capital, a leading investor in early-stage life sciences companies, announced today that Alex Arfaei has joined the firm as a Partner of Pappas Ventures. In his role, Mr. Arfaei will be responsible for helping to identify and evaluate investment opportunities for the firm's venture capital business. Previously, Mr. Arfaei served as a Managing Director with BMO Capital Markets, where he was a senior equity research analyst covering major pharmaceutical and biotechnology companies.